Multiple immune cell populations and cytokines within the ocular microenvironment via UCMSC-derived factors

This entry describes a complex therapeutic mechanism rather than a single molecular target. It refers to the immunomodulatory effects of factors secreted by Umbilical Cord Mesenchymal Stem Cells (UCMSCs) on various immune cells and signaling molecules within the ocular microenvironment (Li et al., 2021, Frontiers in Cell and Developmental Biology). These factors, which include cytokines, growth factors, and extracellular vesicles, act to restore immune homeostasis in inflammatory ocular conditions such as uveitis, dry eye disease, and corneal graft rejection (Harrell et al., 2018, International Journal of Molecular Sciences). By interacting with T cells, macrophages, and dendritic cells, UCMSC-derived factors suppress pro-inflammatory pathways and enhance anti-inflammatory signaling (Wang et al., 2020, Stem Cell Research & Therapy). Specifically, they inhibit the production of IFN-gamma and TNF-alpha while promoting the secretion of IL-10 and TGF-beta. This process also involves the induction of regulatory T cells (Tregs) and the polarization of macrophages toward the anti-inflammatory M2 phenotype. Consequently, this target represents a multi-faceted approach to treating ocular inflammation by reshaping the entire local immune landscape. Because it involves a broad secretome acting on a heterogeneous cell population, it does not fit the classical definition of a single drug target.

Other names

UCMSC-mediated ocular immunomodulationUmbilical cord mesenchymal stem cell secretomeUCMSC-derived paracrine factorsUCMSC-mediated immune microenvironment modulation

UCMSC-derived factors (such as TGF-beta, IL-10, and PGE2) modulate the ocular microenvironment by inhibiting pro-inflammatory Th1 and Th17 cell differentiation, promoting regulatory T cell (Treg) expansion, and inducing M2 macrophage polarization (Li et al., 2021; Wang et al., 2020).